Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |